Business

February 5, 2014

GSK’s China drug sales continue falling in bribery scandal fallout

GlaxoSmithKline’s drug sales continued falling in China amid the fallout from a bribery scandal in that country, but global sales made up for the Chinese setback and contributed to GSK’s overall sales growth in the fourth quarter.

Related content

Comments

Videos

Editor's Choice Videos